Pulmonxcorp Stock Target Price
| LUNG Stock | USD 9.82 0.44 4.69% |
PulmonxCorp fundamentals help investors to digest information that contributes to PulmonxCorp's financial success or failures. It also enables traders to predict the movement of PulmonxCorp Stock. The fundamental analysis module provides a way to measure PulmonxCorp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PulmonxCorp stock.
PulmonxCorp | Target Price |
PulmonxCorp Target Price Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PulmonxCorp's direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PulmonxCorp could also be used in its relative valuation, which is a method of valuing PulmonxCorp by comparing valuation metrics of similar companies.PulmonxCorp is currently under evaluation in target price category among related companies.
PulmonxCorp Current Valuation Drivers
We derive many important indicators used in calculating different scores of PulmonxCorp from analyzing PulmonxCorp's financial statements. These drivers represent accounts that assess PulmonxCorp's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of PulmonxCorp's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.4B | 2.5B | 1.2B | 312.7M | 484.2M | 460.0M | |
| Enterprise Value | 1.4B | 2.3B | 1.0B | 235.4M | 441.8M | 419.7M |
PulmonxCorp Fundamentals
| Return On Equity | -0.46 | ||||
| Return On Asset | -0.21 | ||||
| Profit Margin | (0.80) % | ||||
| Operating Margin | (0.77) % | ||||
| Current Valuation | 303.85 M | ||||
| Shares Outstanding | 38.81 M | ||||
| Shares Owned By Insiders | 4.67 % | ||||
| Shares Owned By Institutions | 92.80 % | ||||
| Number Of Shares Shorted | 1.73 M | ||||
| Price To Book | 2.59 X | ||||
| Price To Sales | 4.46 X | ||||
| Revenue | 68.67 M | ||||
| Gross Profit | 39.87 M | ||||
| EBITDA | (59.99 M) | ||||
| Net Income | (60.84 M) | ||||
| Cash And Equivalents | 162.09 M | ||||
| Cash Per Share | 4.35 X | ||||
| Total Debt | 41.42 M | ||||
| Debt To Equity | 0.15 % | ||||
| Current Ratio | 9.43 X | ||||
| Book Value Per Share | 2.86 X | ||||
| Cash Flow From Operations | (37.61 M) | ||||
| Short Ratio | 2.57 X | ||||
| Earnings Per Share | (1.60) X | ||||
| Price To Earnings To Growth | (0.42) X | ||||
| Target Price | 15.4 | ||||
| Number Of Employees | 279 | ||||
| Beta | 0.6 | ||||
| Market Capitalization | 381.13 M | ||||
| Total Asset | 178.95 M | ||||
| Retained Earnings | (411.16 M) | ||||
| Working Capital | 127.27 M | ||||
| Net Asset | 178.95 M |
About PulmonxCorp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PulmonxCorp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PulmonxCorp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PulmonxCorp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards PulmonxCorp in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, PulmonxCorp's short interest history, or implied volatility extrapolated from PulmonxCorp options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out PulmonxCorp Piotroski F Score and PulmonxCorp Altman Z Score analysis. For more detail on how to invest in PulmonxCorp Stock please use our How to Invest in PulmonxCorp guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Complementary Tools for PulmonxCorp Stock analysis
When running PulmonxCorp's price analysis, check to measure PulmonxCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PulmonxCorp is operating at the current time. Most of PulmonxCorp's value examination focuses on studying past and present price action to predict the probability of PulmonxCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PulmonxCorp's price. Additionally, you may evaluate how the addition of PulmonxCorp to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |
Is PulmonxCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PulmonxCorp. If investors know PulmonxCorp will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PulmonxCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.60) | Revenue Per Share 1.909 | Quarterly Revenue Growth 0.297 | Return On Assets (0.21) | Return On Equity (0.46) |
The market value of PulmonxCorp is measured differently than its book value, which is the value of PulmonxCorp that is recorded on the company's balance sheet. Investors also form their own opinion of PulmonxCorp's value that differs from its market value or its book value, called intrinsic value, which is PulmonxCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PulmonxCorp's market value can be influenced by many factors that don't directly affect PulmonxCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PulmonxCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if PulmonxCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PulmonxCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.